• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Insights in cardiovascular endocrinology: 2023.

作者信息

Santulli Gaetano

机构信息

Department of Medicine, Wilf Family Cardiovascular Research Institute, Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, New York, NY, United States.

Department of Molecular Pharmacology, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Aging Research, Institute for Neuroimmunology and Inflammation (INI), Albert Einstein College of Medicine, New York, NY, United States.

出版信息

Front Endocrinol (Lausanne). 2023 Aug 4;14:1266221. doi: 10.3389/fendo.2023.1266221. eCollection 2023.

DOI:10.3389/fendo.2023.1266221
PMID:37600701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10436608/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1e/10436608/0d3e21d20a32/fendo-14-1266221-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1e/10436608/0d3e21d20a32/fendo-14-1266221-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb1e/10436608/0d3e21d20a32/fendo-14-1266221-g001.jpg

相似文献

1
Editorial: Insights in cardiovascular endocrinology: 2023.社论：心血管内分泌学见解：2023年。
Front Endocrinol (Lausanne). 2023 Aug 4;14:1266221. doi: 10.3389/fendo.2023.1266221. eCollection 2023.
2
Editorial: Rising stars in cardiovascular endocrinology 2022.社论：2022年心血管内分泌学领域的后起之秀
Front Endocrinol (Lausanne). 2023 Mar 13;14:1175403. doi: 10.3389/fendo.2023.1175403. eCollection 2023.
3
Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry.心血管内科和内分泌科医生对高血压和糖尿病的管理：一项中国登记研究
J Hypertens. 2016 Aug;34(8):1648-53. doi: 10.1097/HJH.0000000000000994.
4
[Endocrinological aspects of cardiology: the successes and problems].
Kardiologiia. 1979 Mar;19(3):5-10.
5
Coronary microvascular disease: The "Meeting Point" of Cardiology, Rheumatology and Endocrinology.冠状动脉微血管疾病：心脏病学、风湿病学与内分泌学的“交汇点”
Eur J Clin Invest. 2022 May;52(5):e13737. doi: 10.1111/eci.13737. Epub 2022 Jan 4.
6
Diabetic cardiovascular disease lost in translation between endocrinology and cardiology.糖尿病心血管疾病在内分泌学和心脏病学之间的转化中被忽视了。
Am J Cardiol. 2008 Oct 15;102(8):1115-6. doi: 10.1016/j.amjcard.2008.08.006.
7
The Fifth Annual Heart in Diabetes Conference (Part 1).
J Diabetes. 2021 Dec;13(12):946-948. doi: 10.1111/1753-0407.13231. Epub 2021 Oct 19.
8
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.美国临床内分泌医师协会和美国内分泌学会血脂异常管理与心血管疾病预防指南
Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL.
9
Development of the Clinic of Endocrinology, diabetes and metabolic disorders.内分泌、糖尿病及代谢紊乱诊所的发展。
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2013;34(1):75-8.
10
Editorial: Community series in SIRT family in endocrinology.社论：内分泌学中SIRT家族的社区系列
Front Endocrinol (Lausanne). 2023 Mar 16;14:1163226. doi: 10.3389/fendo.2023.1163226. eCollection 2023.

本文引用的文献

1
The severity of valvular heart disease in euthyroid individuals is associated with thyroid hormone levels but not with TSH levels.在甲状腺功能正常的个体中，心脏瓣膜病的严重程度与甲状腺激素水平相关，而与 TSH 水平无关。
Front Endocrinol (Lausanne). 2023 Jul 4;14:1193557. doi: 10.3389/fendo.2023.1193557. eCollection 2023.
2
Atrial natriuretic peptide and leptin interactions in healthy men.健康男性心房利钠肽和瘦素的相互作用。
Front Endocrinol (Lausanne). 2023 Jun 30;14:1195677. doi: 10.3389/fendo.2023.1195677. eCollection 2023.
3
Editorial: The link between obesity, type 2 diabetes, and mitochondria.
社论：肥胖、2型糖尿病与线粒体之间的联系
Front Endocrinol (Lausanne). 2023 Jun 20;14:1229935. doi: 10.3389/fendo.2023.1229935. eCollection 2023.
4
Editorial: Rising stars in cardiovascular endocrinology 2022.社论：2022年心血管内分泌学领域的后起之秀
Front Endocrinol (Lausanne). 2023 Mar 13;14:1175403. doi: 10.3389/fendo.2023.1175403. eCollection 2023.
5
Editorial: Leptin, obesity and diet at a glance.
Front Endocrinol (Lausanne). 2022 Nov 9;13:1073850. doi: 10.3389/fendo.2022.1073850. eCollection 2022.
6
Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System.SGLT2 抑制剂和 GLP-1 受体激动剂对肾素-血管紧张素-醛固酮系统的影响。
Front Endocrinol (Lausanne). 2021 Oct 21;12:738848. doi: 10.3389/fendo.2021.738848. eCollection 2021.
7
Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases.心血管内分泌学：相关疾病的概念演变与最新流行病学
Front Endocrinol (Lausanne). 2021 Oct 5;12:772876. doi: 10.3389/fendo.2021.772876. eCollection 2021.
8
The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities.明显或亚临床心脏结节病患者的检查与管理：重点关注相关的心律异常。
J Cardiovasc Electrophysiol. 2009 May;20(5):578-83. doi: 10.1111/j.1540-8167.2008.01417.x. Epub 2009 Jan 9.